Comparison of sclerosing cholangitis with autoimmune pancreatitis and infi ltrative extrahepatic cholangiocarcinoma: Multidetector-row computed tomography fi ndings

Japanese Journal of Radiology

Volumn 28, Issue 3, 2010, Pages 205-213

  Arikawa, Shunji ^a   Uchida, Masafumi ^a   Kunou, Yukiko ^a   Uozumi, Jun ^a   Abe, Toshi ^a   Hayabuchi, Naofumi ^a   Ishida, Yusuke ^a   Kaji, Ryohei ^a   Okabe, Yoshinobu ^a   Murotani, Kenta ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY   (Japan)

Author keywords

Infi ltrative extrahepatic cholangiocarcinoma (IEC); Multidetector row computed tomography (MDCT); Sclerosing cholangitis with autoimmune pancreatitis (SC AIP)

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE PANCREATITIS; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; GALLBLADDER; HUMAN; INFILTRATIVE EXTRAHEPATIC CHOLANGIOCARCINOMA; INTRAHEPATIC BILE DUCT; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATITIS, CHRONIC; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77954608043     PISSN: 18671071     EISSN: 1867108X     Source Type: Journal    
DOI: 10.1007/s11604-009-0410-8     Document Type: Article

References (32)

1. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002;51:1-4.
2. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality: proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995;40:1561-1568.
3. Irie H, Honda H, Baba S, Kuroiwa T, Yoshimitsu K, Tajima T, et al. Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol 1998;170:1323-27.
4. Sahani DV, Kalva SP, Farrell J, Maher MM, Saini S, Mueller PR, et al. Autoimmune pancreatitis: imaging features. Radiology 2004;233:345-2.
5. Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4- related autoimmune disease. J Gastroenterol 2003;38:982-4.
6. Kamisawa T, Tu Y, Nakajima H, Egawa N, Tsuruta K, Okamoto A, et al. Sclerosing cholecystitis associated with autoimmune pancreatitis. World J Gastroenterol 2006;12: 3736-9.
7. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Extrapancreatic lesions in autoimmune pancreatitis. J Clin Gastroenterol 2005;39:904-7.
8. Kamisawa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fi brosis with lymphadenopathy. Pancreatology 2006;6: 132-7.
9. Hayashi K, Nakazawa T, Ohara H, Ando T, Takada H, Tanaka H, et al. Autoimmune sclerosing cholangiopancreatitis with little pancreatic involvements by imaging findings. Hepatogastroenterology 2007;54:2146-51.
10. Hamano H, Kawa S, Uehara T, Ochi Y, Takayama M, Komatsu K, et al. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infi ltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc 2005;62:152-7.
11. Kuroiwa T, Suda T, Takahashi T, Hirono H, Natsui M, Motoyama H, et al. Bile duct involvement in a case of autoimmune pancreatitis successfully treated with an oral steroid. Dig Dis Sci 2002;47:1810-16.
12. Okazaki K, Kawa S, Kamisawa T, Naruse S, Tanaka S, Nishimori I, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006;41:626-31.
13. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-8.
14. John AR, Haghighi KS, Taniere P, Esmat ME, Tan YM, Bramhall SR. Is a raised CA 19-9 level diagnostic for a cholangiocarcinoma in patients with no history of sclerosing cholangitis? Dig Surg 2006;23:319-24.
15. Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995;108:865-869.
16. Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney DM, Ritts RE Jr. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 1993;68:874-79.
17. Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000;95:204-7.
18. Ghazale A, Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007;102:1646-1653.
19. Park MS, Lee DK, Kim MJ, Lee WJ, Yoon DS, Lee SJ, et al. Preoperative staging accuracy of multidetector row computed tomography for extrahepatic bile duct carcinoma. J Comput Assist Tomogr 2006;30:362-7.
20. Cho ES, Park MS, Yu JS, Kim MJ, Kim KW. Biliary ductal involvement of hilar cholangiocarcinoma: multidetector computed tomography versus magnetic resonance cholangiography. J Comput Assist Tomogr 2007;31:72-8.
21. Ahmetoglu A, Kosucu P, Kul S, Dinc H, Sari A, Arslan M, et al. MDCT cholangiography with volume rendering for the assessment of patients with biliary obstruction. AJR Am J Roentgenol 2004;183:1327-32.
22. Kim HJ, Kim AY, Hong SS, Kim MH, Byun JH, Won HJ, et al. Biliary ductal evaluation of hilar cholangiocarcinoma: three-dimensional direct multi-detector row CT cholangiographic findings versus surgical and pathologic results? feasibility study. Radiology 2006;238:300-8.
23. Choi SH, Han JK, Lee JM, Lee KH, Kim SH, Lee JY, et al. Differentiating malignant from benign common bile duct stricture with multiphasic helical CT. Radiology 2005;236: 178-3.
24. Rosch T, Meining A, Fruhmorgen S, Zillinger C, Schusdziarra V, Hellerhoff K, et al. A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc 2002;55:870-6.
25. Park MS, Kim TK, Kim KW, Park SW, Lee JK, Kim JS, et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology 2004;233:234-40.
26. Soto JA, Alvarez O, Lopera JE, Munera F, Restrepo JC, Correa G.. Biliary obstruction: findings at MR cholangiography and cross-sectional MR imaging. Radiographics 2000; 20:353-6.
27. Baron RL. Computed tomography of the biliary tree. Radiol Clin North Am 1991;29:1235-50.
28. Han JK, Choi BI, Kim AY, An SK, Lee JW, Kim TK, et al. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics 2002;22:173-7.
29. Hyodo N, Hyodo T. Ultrasonographic evaluation in patients with autoimmune-related pancreatitis. J Gastroenterol 2003; 38:1155-61.
30. Hirano K, Shiratori Y, Komatsu Y, Yamamoto N, Sasahira N, Toda N, et al. Involvement of the biliary system in autoimmune pancreatitis: a follow-up study. Clin Gastroenterol Hepatol 2003;1:453-64.
31. Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J, et al. IgG4-related sclerosing cholangitis with and without hepatic infl ammatory pseudotumor, and sclerosing pancreatitis- associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 2004;28:1193-1203.
32. Nishino T, Toki F, Oyama H, Oi I, Kobayashi M, Takasaki K, et al. Biliary tract involvement in autoimmune pancreatitis. Pancreas 2005;30:76-2.